David Younger

David Younger

Co-Founder and CEO at A-Alpha Bio
Seattle, Washington, United States

David Younger is the Co-Founder and CEO at A-Alpha Bio, a biotechnology startup. He has expertise in synthetic biology and protein engineering.

Recent coverage

Front-page news, podcasts and videos about David

See all 10

Trump-Era Funding Cuts and Hiring Freeze Stall UW Protein Design Startups Led by Nobel Laureate David Baker

The University of Washington's Institute for Protein Design, led by Nobel laureate David Baker, faces a hiring freeze and funding cuts under the Trump administration, stalling its promising protein design startups and reducing opportunities for graduate students and postdocs. Despite Nobel-driven interest and advances in AI-designed proteins, budget constraints threaten future innovation and company spinoffs.

Seattle Biotech Startup A-Alpha Bio Raises $22.4M to Advance AI Platform for Protein Interaction Analysis

Seattle biotech startup A-Alpha Bio raised $22.4 million to advance its AI-driven platform that measures protein interactions, partnering with major drug companies like Bristol Myers Squibb and Gilead Sciences to accelerate therapeutic development. Its platform combines computational tools and yeast experiments to analyze nearly 500 million protein-protein interaction measurements for drug discovery.

IA40 Spotlight: A-Alpha Bio's David Younger on machine learning in biotech, building cross-functional teams

This week on Founded & Funded, Partner Chris Picardo is talking with A-Alpha Bio Co-founder and CEO David Younger for our first Intelligent Application 40 Spotlight episode of 2023. We announced the 2022 IA40 winners in October, and A-Alpha was the first biotech company to make the list, which was no surprise to us. As one of our portfolio companies, we know the work David and his team are doing at the intersections of biological and data/computer sciences will change the world — but having a group of judges agree with us makes us all the more certain. Protein interactions…

Organizations

See all 4
  • A-Alpha Bio logo
    A-Alpha Bio Executive Officer, Director 2019–present, Co-Founder and CEO 2017–present · current
  • University of Washington logo
    University of Washington Postdoctoral Researcher 2017–2018, Bioengineering Graduate Student 2012–2017 · past
  • Luminex Corporation Engineering Intern 2011 · past

Education

  • University of Washington Doctor of Philosophy (PhD), Bioengineering · 2012–2017
  • Rice University Bachelor of Science; Bachelor of Arts, Bioengineering, Economics · 2007–2012
  • The London School of Economics and Political Science (LSE) Economics · 2009–2010

Online